Learn more

OLIGENE GMBH

Overview
  • Total Patents
    20
About

OLIGENE GMBH has a total of 20 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and medical technology are PRIMERADX INC, SANSURE BIOTECH INC and TAI DIAGNOSTICS INC.

Patent filings in countries

World map showing OLIGENE GMBHs patent filings in countries

Patent filings per year

Chart showing OLIGENE GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Haeupl Thomas 10
#2 Burmester Gerd-Ruediger 5
#3 Stuhlmueller Bruno 5
#4 Dietel Manfred 4
#5 Denkert Carsten 3
#6 Gruen Joachim 3
#7 Kaps Christian 3
#8 Kiesslich Olaf 3
#9 Radbruch Andreas 3
#10 Gruetzkau Andreas 3

Latest patents

Publication Filing date Title
EP1806413A1 An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer
EP1795610A1 A composition of nucleic acid sequences, specific for inflammatory disease, in particular rheumatoid arthritis
DE102004016437A1 Method for detecting signatures in complex gene expression profiles
DE10353803A1 Diagnostic, prognostic and therapeutic procedures in the investigation and treatment of malignant tumors
DE10351717A1 Device for determining resistance to pharmaceuticals, used particularly for selection of anticancer agents, comprises an array of nucleic acid sequences or derived proteins from specific genes
DE10311981A1 Device for application, extraction and storage of biological material, includes immobilizing substrate for e.g. diagnosis, therapy or application
DE10234524A1 Array of probes derived from monocyte-macrophage genes, useful e.g. for diagnosis, prognosis and therapeutic monitoring of rheumatoid arthritis and other inflammatory diseases
DE10225853A1 Tool for diagnosis of chronic and other inflammatory disease, infection and tumors, also for molecular studies and therapy development, based on selected genes
DE10155600A1 Nucleic acid array